Majem M - Search Results

1

Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer.

Chmielecki J, Gray JE, Cheng Y, Ohe Y, Imamura F, Cho BC, Lin MC, Majem M, Shah R, Rukazenkov Y, Todd A, Markovets A, Barrett JC, Hartmaier RJ, Ramalingam SS. Chmielecki J, et al. Among authors: majem m. Nat Commun. 2023 Feb 27;14(1):1070. doi: 10.1038/s41467-023-35961-y. Nat Commun. 2023. PMID: 36849494 Free PMC article.

2

SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016).

de Las Peñas R, Blasco A, De Castro J, Escobar Y, García-Campelo R, Gúrpide A, Lopez-Lopez R, Majem M, Rodríguez CA, Virizuela JA. de Las Peñas R, et al. Among authors: majem m. Clin Transl Oncol. 2016 Dec;18(12):1237-1242. doi: 10.1007/s12094-016-1583-0. Epub 2016 Nov 28. Clin Transl Oncol. 2016. PMID: 27896642 Free PMC article.

3

SEOM clinical guideline for the management of cutaneous melanoma (2020).

Majem M, Manzano JL, Marquez-Rodas I, Mujika K, Muñoz-Couselo E, Pérez-Ruiz E, de la Cruz-Merino L, Espinosa E, Gonzalez-Cao M, Berrocal A. Majem M, et al. Clin Transl Oncol. 2021 May;23(5):948-960. doi: 10.1007/s12094-020-02539-9. Epub 2021 Mar 2. Clin Transl Oncol. 2021. PMID: 33651321 Free PMC article.

4

Control of E1A under an E2F-1 promoter insulated with the myotonic dystrophy locus insulator reduces the toxicity of oncolytic adenovirus Ad-Delta24RGD.

Majem M, Cascallo M, Bayo-Puxan N, Mesia R, Germa JR, Alemany R. Majem M, et al. Cancer Gene Ther. 2006 Jul;13(7):696-705. doi: 10.1038/sj.cgt.7700940. Epub 2006 Feb 24. Cancer Gene Ther. 2006. PMID: 16498429

5

Gender influence on work satisfaction and leadership for medical oncologists: a survey of the Spanish Society of Medical Oncology (SEOM).

Elez E, Ayala F, Felip E, García Campelo R, García Carbonero R, García Donás J, González Del Alba A, González Flores E, Hidalgo J, Isla D, Majem M, Rodríguez Lescure Á, Safont MJ, Santaballa A, Villacampa G, Vera R, Garrido P. Elez E, et al. Among authors: majem m. ESMO Open. 2021 Apr;6(2):100048. doi: 10.1016/j.esmoop.2021.100048. Epub 2021 Feb 6. ESMO Open. 2021. PMID: 33556897 Free PMC article.

6

Imaging techniques contribute to increased surgical rescue of relapse in the follow-up of colorectal cancer.

Arriola E, Navarro M, Parés D, Muñoz M, Pareja L, Figueras J, Soler G, Martinez M, Majem M, Germa-Lluch JR. Arriola E, et al. Among authors: majem m. Dis Colon Rectum. 2006 Apr;49(4):478-84. doi: 10.1007/s10350-005-0280-9. Dis Colon Rectum. 2006. PMID: 16450212

7

Immunotherapy-induced isolated ACTH deficiency in cancer therapy.

Iglesias P, Peiró I, Biagetti B, Paja-Fano M, Cobo DA, García Gómez C, Mateu-Salat M, Genua I, Majem M, Riudavets M, Gavira J, Lamas C, Fernández Pombo A, Guerrero-Pérez F, Villabona C, Cabezas Agrícola JM, Webb SM, Díez JJ. Iglesias P, et al. Among authors: majem m. Endocr Relat Cancer. 2021 Oct 27;28(12):783-792. doi: 10.1530/ERC-21-0228. Endocr Relat Cancer. 2021. PMID: 34609950

8

Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.

Majem M, Mesia R, Mañós M, Gomez J, Galiana R, Cardenal F, Juan A, Montes A, Perez FJ, Nogues J, Llluch JR. Majem M, et al. Laryngoscope. 2006 Sep;116(9):1651-6. doi: 10.1097/01.mlg.0000231736.08477.47. Laryngoscope. 2006. PMID: 16954998

9

Phase I and pharmacokinetic study of trabectedin 3-hour infusion every three weeks in patients with advanced cancer and alteration of hepatic function.

Pardo B, Salazar R, Ciruelos E, Cortés-Funes H, García M, Majem M, Montes A, Cuadra C, Soto-Matos A, Lebedinsky C, Alfaro V, Paz-Ares L. Pardo B, et al. Among authors: majem m. Med Oncol. 2012 Sep;29(3):2240-50. doi: 10.1007/s12032-011-9979-8. Epub 2011 Jun 10. Med Oncol. 2012. PMID: 21660618 Clinical Trial.

10

Phase I/II docetaxel plus concurrent hyperfractionated radiotherapy in locally advanced unresectable head and neck cancer (TAX.ES1.102 study).

Barnadas A, Mesía R, Majem M, Galiana R, López-Pousa A, de Vega JM, Margelí M, Valentí V, Anglada L, Lloansí A, Arellano A. Barnadas A, et al. Among authors: majem m. Clin Transl Oncol. 2011 Apr;13(4):254-60. doi: 10.1007/s12094-011-0650-9. Clin Transl Oncol. 2011. PMID: 21493186 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

160 results

Search Page